合成阿片类药物贩运

Search documents
OFAC制裁中国一化工公司,称其贩运阿片类药物
制裁名单· 2025-09-04 01:08
Group 1 - The U.S. Treasury's Office of Foreign Assets Control (OFAC) has imposed sanctions on Guangzhou Tengyue Chemical Co., Ltd for its involvement in the production and sale of synthetic opioids to U.S. citizens [1] - The company also sells dangerous analgesic chemicals that are commonly used as diluents and mixed with synthetic opioids and other illegal drugs [1] - OFAC has sanctioned representatives Huang Xiaojun and Huang Zhanpeng for coordinating the shipment of these illegal drugs and diluents to the U.S. [1] Group 2 - In August 2023, Guangzhou Tengyue agreed to sell one kilogram of nitazene to a U.S. buyer, assuring that the package would pass through U.S. customs [1] - Despite a court indictment in October 2024, the company continued its operations and coordinated the sale and shipment of another analgesic, metonitazene, to U.S. customers in early 2025 [1] - A report from the U.S. Drug Enforcement Administration (DEA) in January 2024 highlighted the addictive nature of nitazene, which can lead to respiratory depression and potentially death [2] Group 3 - The National Institute on Drug Abuse reported an increase in the presence of a chemical called xylazine, commonly referred to as "tranq," which is often used as an adulterant in synthetic opioids [2] - Xylazine does not respond to naloxone (Narcan), increasing the risk of death from overdose [2]